Lipids Metabolism and Cardiometabolic Diseases
Cardiometabolic diseases (CMD) remains the major cause of morbidity and mortality in Western countries, with a marked increased in the last years [...]
Main Authors: | Melania Gaggini, Cristina Vassalle |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/24/17460 |
Similar Items
-
Type 2 Diabetes and Oxidative Stress and Inflammation: Pathophysiological Mechanisms and Possible Therapeutic Options
by: Cristina Vassalle, et al.
Published: (2022-05-01) -
Interplay between Vitamin D and Sphingolipids in Cardiometabolic Diseases
by: Simona Fenizia, et al.
Published: (2023-12-01) -
Sphingolipid Levels and Signaling via Resveratrol and Antioxidant Actions in Cardiometabolic Risk and Disease
by: Melania Gaggini, et al.
Published: (2023-05-01) -
Ceramides as Mediators of Oxidative Stress and Inflammation in Cardiometabolic Disease
by: Melania Gaggini, et al.
Published: (2022-02-01) -
Lipids in Atherosclerosis: Pathophysiology and the Role of Calculated Lipid Indices in Assessing Cardiovascular Risk in Patients with Hyperlipidemia
by: Melania Gaggini, et al.
Published: (2022-12-01)